Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 534-538

  Katakami, Naoto ^a   Kaneto, Hideaki ^a   Matsuoka, Taka aki ^a   Takahara, Mitsuyoshi ^a   Imamura, Kenichi ^b   Ishibashi, Fukashi ^c   Kanda, Tsutomu ^d   Kawai, Koichi ^e   Osonoi, Takeshi ^f   Kashiwagi, Atsunori ^g   Kawamori, Ryuzo ^h   Matsuhisa, Munehide ⁱ   Shimomura, Iichiro ^a   Yamasaki, Yoshimitsu ^j  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Imamura Clinic   (Japan)

^c Ishibashi Clinic   (Japan)

^d Kanda Naika Clinic   (Japan)

^e Kawai Clinic   (Japan)

^f Naka Memorial Clinic   (Japan)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TOKUSHIMA   (Japan)

^j OSAKA UNIVERSITY   (Japan)

more..

Author keywords

Atherosclerosis; Diabetes; Myocardial infarction; Oxidative stress; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMATE CYSTEINE LIGASE; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; DIABETIC PATIENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL;

AGED; ATHEROSCLEROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDANTS; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RISK;

EID: 77957697162     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.06.010     Document Type: Article

References (30)

1. West I.C. Radicals in oxidative stress in diabetes. Diabet Med 2002, 17:171-180.
2. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
3. Minova H.R., Mulcahy R.T. An electrophile responsive element (EpRE) regulates gamma-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. J Biol Chem 1998, 273:14683-14689.
4. Nakamura S., Kugiyama K., Sugiyama S., et al. Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002, 105:2968-2973.
5. Lebovitz R.M., Zhang H., Vogel H., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996, 93:9782-9787.
6. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996, 226:561-565.
7. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003, 13:145-157.
8. Shimoda-Matsubayashi S., Hattori T., Matsumine H., et al. MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson' disease and control. Neurology 1997, 49:1257-1262.
9. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000, 97:2832-2835.
10. Wang X.L., Sim A.S., Wang M.X., Murrell G.A., Trudinger B., Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 2000, 471:45-50.
11. Veldman B.A., Spiering W., Doevendans P.A., et al. The Glu298Asp polymorphism of the NOS3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002, 20:2023-2027.
12. Noiri E., Satoh H., Taguchi J., et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002, 40:535-540.
13. Azumi H., Inoue N., Takeshita S., et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 1999, 100:1494-1498.
14. Guzik T.J., West N.E., Black E., et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000, 102:1744-1747.
15. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994, 94:437-444.
16. Reynolds W.F., Chang E., Douer E., Ball E.D., Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukaemia. Blood 1997, 90:2730-2737.
17. Aviram M., Hardak E., Vaya J., et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000, 101:2510-2517.
18. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
19. Dupont W.P., Plummer W.D. Power and sample size calculations: a review and computer program. Control Clin Trials 1990, 11:116-128.
20. Keating B.J., Tischfield S., Murray S.S., et al. Concept, design and implementation of cardiovascular gene-centric 50K SNP array for large-scale genomic association studies. PLoS one 2008, 3:e3583.
21. Yang Q., Khoury M.J., Botto L., Friedman J.M., Flanders W.D. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003, 72:636-649.
22. Cam S.F., Sekuri C., Tengiz I., et al. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 2005, 116:278-292.
23. Tamemoto H., Ishikawa S.E., Kawakami M. Association of the Glu298Asp polymorphism of the eNOS gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract 2008, 80:275-279.
24. Jaramillo P.C., Munoz M.A., Lanas M.C., Lanas Z.F., Salazar L.A. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2006, 371:102-106.
25. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
26. Soccio M., Toniato E., Evangelista V., Carluccio M., De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 2005, 35:305-314.
27. Nikpoor B., Turecki G., Fournier C., Theroux P., Rouleau G.A. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001, 142:336-339.
28. Makela R., Loimaala A., Nenonen A., et al. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes. Clin Biochem 2008, 41:532-553.
29. Wainstein R.V., Wainstein M.V., Riberio J.P., et al. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease. Clin Biochem 2010, 43:57-62.
30. Fujimoto H., Taguchi J., Imai Y., et al. Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur Heart J 2008, 29:1267-1274.